Becton, Dickinson& Co. rose$. 05 or percent, to $143.44. PerkinElmer fell$. 30 or. 7 percent, to $45.63. Thermo Fisher Scientific Inc. fell$. 29 or. 2 percent, to $127.50.
Becton, Dickinson& Co. fell$. 50 or. 3 percent, to $143.39. PerkinElmer fell$. 44 or. 9 percent, to $45.93. Thermo Fisher Scientific Inc. fell$. 21 or. 2 percent, to $127.79.
Becton, Dickinson& Co. fell$. 79 or. 5 percent, to $143.10. PerkinElmer fell$. 25 or. 5 percent, to $46.12. Thermo Fisher Scientific Inc. fell$. 29 or. 2 percent, to $127.71.
Becton, Dickinson& Co. fell$. 52 or. 4 percent, to $143.37. PerkinElmer fell$. 29 or. 6 percent, to $46.08. Thermo Fisher Scientific Inc. fell$. 28 or. 2 percent, to $127.72.
Jan 29- Scientific instruments maker PerkinElmer Inc on Thursday reported better-than-expected fourth quarter revenue and profit, helped by strong demand for its newborn screening tests in developing markets. PerkinElmer, which also sells environmental and food safety testing equipment, gets more than half of its revenue from sales outside the United...
Oct 30- PerkinElmer Inc on Thursday reported lower-than-expected third-quarter sales and the scientific instruments maker decreased its full-year earnings forecast, citing the impact of the stronger dollar on foreign exchange rates. PerkinElmer gets more than half of its revenue from sales outside the United States. Excluding items, PerkinElmer said it...
Adjusting to a world with less Fed liquidity has created pain in those markets with current account deficiencies, weak currencies and inflation.
Check out which companies are making headlines after the bell Monday:
Jim Cramer thinks this company could unlock significant value with the simple stroke of a pen.
Check out which companies are making headlines after the bell Thursday:
Shares of PerkinElmer soared to a new annual high, a day after the health and industrial sciences company reported third-quarter results that topped Wall Street expectations. PerkinElmer Inc. said Thursday it now expects adjusted 2012 earnings of $2.05 to $2.07 per share. THE BIG PICTURE: PerkinElmer runs human and environmental health businesses.
Analyst Sung Ji Nam said that for now, the major sources of growth for companies including Illumina Inc. and Life Technologies Corp. will be sales of new, more advanced gene-sequencing products and disposable items used in testing, and their biggest clients will remain academic and clinical customers.
*JP Morgan starts PerkinElmer with overweight- Streetinsider.com. Reuters Station users, click. 1568. Reuters Station users, click. 4899.
NEW YORK-- Analysts for Cowen and Co. started coverage of a group of companies that make tests used to diagnose infectious diseases, assigning top ratings to companies including Cepheid, Hologic Inc., and Meridian Bioscience Inc..
Take a look at some of Tuesday’s morning movers:
Cramer makes the call on viewers' favorite stocks.
What follows is a look at stocks in the S&P 1,500 displaying unusual volume in Tuesday's trading session.
The Lightning Round is extended in this CNBC.com exclusive feature.
Cramer thinks this is it. Check out his interview with this company's CEO.
Japan's nuclear crisis could give added business to a company already doing "incredibly well."